Serologicals Shareholders Approve Millipore's $1.4B Buyout | GenomeWeb
NEW YORK (GenomeWeb News) - Serologicals shareholders have approved Millipore's buyout offer, Serologicals said today.
GenomeWeb News on April 25 reported Millipore's plan to acquire Serologicals for $1.4 billion. The shareholders will receive $31.55 per share in cash.
About 82 percent of shares outstanding voted in favor of the deal, the Atlanta-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.